The purpose of this study is to study the safety and feasibility of mobilization of acute ischemic stroke patients treated with IV-tPA between 12-24 hours of treatment.
No linked publications found in PubMed
Inclusion Criteria: * Patients post acute ischemic stroke that have been treated with intravenous tissue plasminogen activator (IV-tPA) * 13 hours have elapsed since initiation of intravenous TPA infusion * Patients are hemodynamically stable (e.g., not on vasopressors or antihypertensive drips or requiring multiple IV PRN boluses of either medication) * Patient is able to actively engage in the evaluation Exclusion Criteria: * Patients with femoral sheaths or recent removal of femoral sheaths * Patients who are hemodynamically unstable, with active bleeding from lines, catheters, INT site or wounds or angioedema * Electrocardiogram showing (HR\>100) * Vital signs (HR \> 100, SBP \<90 or \>180, DBP \<70 or \> 105) * Patients experiencing marked diaphoresis, facial pallor, intense anxious or painful facial expression (especially in aphasic patients)